Korean J Physiol Pharmacol.
2000 Aug;4(4):291-299.
Changes of the level of G protein alpha-subunit mRNA by withdrawal from
morphine and butorphanol
- Affiliations
-
- 1Department of Neuroscience and Medical Research Center, College of
Medicine, Ewha Womans University, Yangchon-ku, Seoul, South Korea.
Abstract
- Morphine or butorphanol was continuously infused into cerebroventricle
(i.c.v.) with the rate of 26 nmol/microliter/h for 3 days, and the withdrawal
from opioid was rendered 7 hrs after the stopping of infusion. The
expression of physical dependence produced by these opioids was
evaluated by measuring the naloxone-precipitated withdrawal signs. The
withdrawal signs produced in animals dependent on butorphanol (kappa
opioid receptor agonist) were similar to those of morphine (mu opioid
receptor agonist). Besides the behavioral modifications, opioid
withdrawal affected G protein expression in the central nervous system.
The G-protein alpha-subunit has been implicated in opioid tolerance and
withdrawal. The effects of continuous infusion of morphine or
butorphanol on the modulation of G protein alpha-subunit mRNA were
investigated by using in situ hybridization study. In situ
hybridization showed that the levels of G alphas and G alphai were
changed during opioid withdrawal. Specifically, the level of G alphas
mRNA was decreased in the cortex and cerebellar granule layer during
the morphine and butorphanol withdrawal. The level of G alphai mRNA was
decreased in the dentate gyrus and cerebellar granule layer during the
morphine withdrawal. However, the level of G alphai mRNA was
significantly elevated during the butorphanol withdrawal. These results
suggest that region-specific changes of G protein alpha-subunit mRNA
were involved in the withdrawal from morphine and butorphanol.